Lucía Cabal‐Hierro

Author

Lucía Cabal‐Hierro

Harvard University ORCID

Also Known As

L. Cabal-Hierro, LUCIA CABAL-HIERRO, Lucia Cabal Hierro, Lucia Cabal-Hierro, Lucía Cabal-Hierro, Lucía Cabal‐Hierro

Publications

Citations

H-Index

Concepts

All Affiliations

Harvard University Dana-Farber Cancer Institute Universidad de Oviedo University of Pennsylvania National Cancer Institute

About

Lucía Cabal‐Hierro is an author at Harvard University specializing in cell biology, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	251
2	Cell Biology	6	6	251
3	Natural Sciences	2	2	41
4	Biochemistry	1	1	11
5	Cellular Physiology	1	1	66

Lucía Cabal‐Hierro

Publications

580

Citations

H-Index

Page 1

	Year	Citations
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax Joan Montero, Jason Stephansky, Tianyu Cai, Cancer Discovery	2016	205
TRAF-mediated modulation of NF-kB AND JNK Activation by TNFR2 Lucía Cabal‐Hierro, Montserrat A. de la Rosa Rodriguez, Noelia Artime, Cellular Signalling InflammationSignal TransductionSignaling PathwayCell SignalingTraf-mediated Modulation	2014	66
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression Cody T. Mowery, Jaime M. Reyes, Lucía Cabal‐Hierro, Cell Reports	2018	65
Chromatin accessibility promotes hematopoietic and leukemia stem cell activity Lucía Cabal‐Hierro, Peter van Galen, Miguel A. Prado, Nature Communications Histone ModificationsChromatinChromatin AccessibilityChromatin OrganizationHematological Malignancy	2020	63
NF-κB Signal Triggering and Termination by Tumor Necrosis Factor Receptor 2 Montserrat A. de la Rosa Rodriguez, Lucía Cabal‐Hierro, María Teresa Carcedo, Journal of Biological Chemistry Amino AcidsNf-κb Signal TriggeringApoptosisImmunologyImmune Regulation	2011	56
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2 Jing Yang, Ellen Weisberg, Xiaoxi Liu, Leukemia Hematological MalignancyNovel TherapyNatural SciencesReceptor Tyrosine KinaseMalignant Blood Disorder	2021	30
Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents Irina A. Vasilevskaya, Muthu Selvakumaran, Lucía Cabal‐Hierro, Clinical Cancer Research	2015	25
A TRAF2 binding independent region of TNFR2 is responsible for TRAF2 depletion and enhancement of cytotoxicity driven by TNFR1 Lucía Cabal‐Hierro, Noelia Artime, Julián Iglesias, Oncotarget Soluble TnfApoptosisImmunologyCell DeathCell Death Mechanisms	2013	25
TNF Signaling through RIP1 Kinase Enhances SN38-Induced Death in Colon Adenocarcinoma Lucía Cabal‐Hierro, Peter J. O’Dwyer Molecular Cancer Research	2017	22
Predictive model for a second hip fracture occurrence using natural language processing and machine learning on electronic health records Ricardo Larrainzar‐Garijo, Esther Fernández-Tormos, Carlos Alberto Collado-Escudero, Scientific Reports	2024	12

Page 1